Tyrosine Kinase Inhibitor-associated Cerebral Arterial Occlusive Disease Treated with High-flow Bypass Surgery: A Case Report

Nilotinib, one of the tyrosine kinase inhibitors, has been used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). Nilotinib-associated cerebral arterial occlusive disease, which is treated with medicine with/without bypass surgery or...

Descripción completa

Detalles Bibliográficos
Autores principales: RAI, Yurie, HARA, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101701/
https://www.ncbi.nlm.nih.gov/pubmed/37065876
http://dx.doi.org/10.2176/jns-nmc.2022-0298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101701/
https://www.ncbi.nlm.nih.gov/pubmed/37065876
http://dx.doi.org/10.2176/jns-nmc.2022-0298

Ejemplares similares